Medtronic plc Stock price

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:55:55 2023-09-29 pm EDT Intraday chart for Medtronic plc 5-day change 1st Jan Change
78.22 USD -0.60% -2.64% +0.55%
Sales 2024 * 32,176 M Sales 2025 * 33,640 M Capitalization 105 B
Net income 2024 * 4,483 M Net income 2025 * 5,153 M EV / Sales 2024 *
3,90x
Net Debt 2024 * 20,676 M Net Debt 2025 * 18,775 M EV / Sales 2025 *
3,67x
P/E ratio 2024 *
23,1x
P/E ratio 2025 *
20,0x
Employees -
Yield 2024 *
3,53%
Yield 2025 *
3,61%
Free-Float99.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.67%
1 week-2.57%
Current month-4.04%
1 month-4.71%
3 months-9.87%
6 months-1.09%
Current year+0.63%
More quotes
1 week
77.44
Extreme 77.435
80.31
1 month
77.44
Extreme 77.435
83.64
Current year
76.02
Extreme 76.02
92.02
1 year
75.77
Extreme 75.765
92.02
3 years
75.77
Extreme 75.765
135.89
5 years
72.13
Extreme 72.13
135.89
10 years
52.44
Extreme 52.44
135.89
More quotes
Date Price Change Volume
23-09-29 78.16 -0.68% 3 775 664
23-09-28 78.69 +0.60% 5,354,099
23-09-27 78.22 -0.92% 7,418,382
23-09-26 78.95 -1.28% 5,166,964
23-09-25 79.97 -0.37% 3,799,682

Delayed Quote Nyse, September 29, 2023 at 03:24 pm EDT

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
78.69USD
Average target price
94.65USD
Spread / Average Target
+20.28%
Consensus
  1. Markets
  2. Equities
  3. Stock Medtronic plc - Nyse
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer